These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators. Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594 [TBL] [Abstract][Full Text] [Related]
3. Overview of patency as an end point of thrombolytic therapy. Anderson JL Am J Cardiol; 1991 Dec; 68(16):11E-16E. PubMed ID: 1746446 [TBL] [Abstract][Full Text] [Related]
5. New developments in thrombolytic therapy. Collen D; Gold HK Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372 [TBL] [Abstract][Full Text] [Related]
6. Patency trials with reteplase (r-PA): what do they tell us? Bode C; Nordt TK; Peter K; Smalling RW; Runge MS; Kübler W Am J Cardiol; 1996 Dec; 78(12A):16-9. PubMed ID: 8990406 [TBL] [Abstract][Full Text] [Related]
7. Thrombolysis and adjunctive therapy in acute myocardial infarction: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Menon V; Harrington RA; Hochman JS; Cannon CP; Goodman SD; Wilcox RG; Schünemann HJ; Ohman EM Chest; 2004 Sep; 126(3 Suppl):549S-575S. PubMed ID: 15383484 [TBL] [Abstract][Full Text] [Related]
8. Influence of time to treatment on early infarct-related artery patency after different thrombolytic regimens. ALKK-Study Group. Zeymer U; Tebbe U; Essen Rv; Haarmann W; Neuhaus KL Am Heart J; 1999 Jan; 137(1):34-8. PubMed ID: 9878934 [TBL] [Abstract][Full Text] [Related]
9. Streptokinase-induced hypotension has no detrimental effect on patients with thrombolytic treatment for acute myocardial infarction. A substudy of the Romanian Study for Accelerated Streptokinase in Acute Myocardial Infarction (ASK-ROMANIA). Tatu-Chiţoiu G; Teodorescu C; Dan M; Guran M; Căpraru P; Istrăţescu O; Tatu-Chiţoiu A; Bumbu A; Chioncel V; Arvanitopol S; Dorobanţu M Rom J Intern Med; 2004; 42(3):557-73. PubMed ID: 16366130 [TBL] [Abstract][Full Text] [Related]
10. Thrombolysis with recombinant unglycosylated single-chain urokinase-type plasminogen activator (saruplase) in acute myocardial infarction: influence of heparin on early patency rate (LIMITS study). Liquemin in Myocardial Infarction During Thrombolysis With Saruplase. Tebbe U; Windeler J; Boesl I; Hoffmann H; Wojcik J; Ashmawy M; Rüdiger Schwarz E; von Loewis P; Rosemeyer P; Hopkins G J Am Coll Cardiol; 1995 Aug; 26(2):365-73. PubMed ID: 7608436 [TBL] [Abstract][Full Text] [Related]
11. [Coronary flow and hemorrhagic complications after alteplase and streptokinase administration in patients with acute myocardial infarction]. Kostić T; Perisić Z; Milić D; Apostolović S; Martinović SS; Bozinović N; Mitov V; Vidanović M Vojnosanit Pregl; 2009 Mar; 66(3):218-22. PubMed ID: 19341228 [TBL] [Abstract][Full Text] [Related]
12. Primary angioplasty versus intravenous thrombolysis for acute myocardial infarction. Cucherat M; Bonnefoy E; Tremeau G Cochrane Database Syst Rev; 2000; (2):CD001560. PubMed ID: 10796812 [TBL] [Abstract][Full Text] [Related]
13. Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapy. Mahaffey KW; Granger CB; Collins R; O'Connor CM; Ohman EM; Bleich SD; Col JJ; Califf RM Am J Cardiol; 1996 Mar; 77(8):551-6. PubMed ID: 8610601 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of streptokinase, but not tissue-type plasminogen activator, in achieving 90-minute patency after thrombolysis for acute myocardial infarction decreases with time to treatment. PERM Study Group. Prospective Evaluation of Reperfusion Markers. Steg PG; Laperche T; Golmard JL; Juliard JM; Benamer H; Himbert D; Aubry P J Am Coll Cardiol; 1998 Mar; 31(4):776-9. PubMed ID: 9525545 [TBL] [Abstract][Full Text] [Related]
15. [Comparative effect of streptokinase and alteplase on electrocardiogram and angiogram signs of myocardial reperfusion in ST segment elevation acute myocardial infarction]. Tomasević M; Kostić T; Apostolović S; Perisić Z; Djordjević-Radojković D; Koraćević G; Salinger-Martinović S Srp Arh Celok Lek; 2008; 136(9-10):481-7. PubMed ID: 19069338 [TBL] [Abstract][Full Text] [Related]
16. Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction: results of the HIT-4 trial. Neuhaus KL; Molhoek GP; Zeymer U; Tebbe U; Wegscheider K; Schröder R; Camez A; Laarman GJ; Grollier GM; Lok DJ; Kuckuck H; Lazarus P J Am Coll Cardiol; 1999 Oct; 34(4):966-73. PubMed ID: 10520777 [TBL] [Abstract][Full Text] [Related]
17. Thrombolysis and percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction. Zeymer U; Neuhaus KL Z Kardiol; 2000; 89 Suppl 4():IV30-40. PubMed ID: 10810775 [TBL] [Abstract][Full Text] [Related]
18. A randomized trial of recombinant staphylokinase versus alteplase for coronary artery patency in acute myocardial infarction. The STAR Trial Group. Vanderschueren S; Barrios L; Kerdsinchai P; Van den Heuvel P; Hermans L; Vrolix M; De Man F; Benit E; Muyldermans L; Collen D Circulation; 1995 Oct; 92(8):2044-9. PubMed ID: 7554180 [TBL] [Abstract][Full Text] [Related]